White label ELPA - ClinicalTrials.eu

Study on Setrusumab for Patients with Osteogenesis Imperfecta (Brittle Bone Disease)

Not recruiting

4 1
Investigated Diseases:
- Osteogenesis imperfecta
Investigated Drugs:
- Setrusumab
Study of Sotorasib Treatment for First-Line Therapy in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with KRAS G12C Mutation

Not recruiting

2 1 1 1
Investigated Diseases:
- Non-small cell lung cancer stage IV
Investigated Drugs:
- Sotorasib
Study on the Safety and Effectiveness of Regtivex and Tocilizumab in Patients Receiving HLA-Mismatched Living Donor Kidney Transplants

Not recruiting

1 1 1 1
Investigated Diseases:
- Renal transplant
Investigated Drugs:
- Regtivex
- Tocilizumab
Study of Tremelimumab, Durvalumab, and Drug Combination for Patients with Advanced Liver Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Hepatocellular carcinoma
Investigated Drugs:
Study on the Effects of Vidofludimus Calcium for Patients with Post-COVID Syndrome

Not recruiting

2 1
Investigated Diseases:
- Post-acute COVID-19 syndrome
Investigated Drugs:
- Vidofludimus Calcium
Study of ACP-204 for Treating Psychosis in Adults with Alzheimer’s Disease

Not recruiting

2 1
Investigated Diseases:
- Dementia Alzheimer’s type
Investigated Drugs:
- Acp-204 Tartrate
Study on Bendamustine, Obinutuzumab, Zanubrutinib, and Venetoclax for Patients with Relapsed Chronic Lymphocytic Leukemia

Not recruiting

2 1 1 1
Investigated Diseases:
- Chronic lymphocytic leukaemia
Investigated Drugs:
Study on Lowering Cholesterol with Rosuvastatin or Rosuvastatin/Ezetimibe in Patients at High or Very High Risk of Cardiovascular Disease with High Cholesterol

Not recruiting

3 1 1 1
Investigated Diseases:
- Hyperlipidaemia
Investigated Drugs:
- Ezetimibe
- Rosuvastatin
Study on Long-Term Use of Spesolimab for Patients with Hidradenitis Suppurativa Who Completed a Previous Spesolimab Study

Not recruiting

4 1
Investigated Diseases:
- Hidradenitis
Investigated Drugs:
- Spesolimab
+8
Study on the Safety and Effects of ATL001 and Pembrolizumab in Adults with Advanced Non-Small Cell Lung Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:
- Atl001
- Pembrolizumab

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies